This week I am joined by the founder and CEO of Indica Skincare, Christoph Richter. Christoph shared stories about setting Indica Skincare up, the amazing qualities CBD can bring to your skincare routine and what it's like pitching to a room of investors on national TV.

This week I am joined by the founder and CEO of Naturecan, Paul Finnegan. We talk about Naturecan's products, values and very exciting research!

A discussion with Angus Taylor about the Canadian legal cannabis landscape and how the UK can learn from their mistakes to foster a positive industry.

This week I am joined by Grayson Hart, a pro athlete and founder of Pure Sport CBD. We discuss the importance of accurate labeling for CBD products used by athletes and how CBD can help with both the physical and mental well-being of athletes.

This week we are joined by Lewis, the co-founder of Cannacares. We have a great discussion about Novel Foods from a brand perspective, and how CBD and other alternative medicines are becoming ever more cardinal in this day and age.

We discuss what it takes to be a leader in the UK CBD Market by drawing on the results of the 2019 New Frontier Data CBD Consumer Survey.

This weeks episode covers the looming Novel Foods validation deadline for the 31st March 2021. Through discussions with Dr Parveen Bhatarah, Isabel Alber and Marc Burbridge we outline the key requirements for a VALID NOVEL FOODS DOSSIER. We also discuss how brands can get involved with the ACI’s safety study. Tune in now to learn about how to stay in the market after 31st March 2021. If you’re a consumer, listen to find out about the amazing research being carried out to ensure your safety when looking to benefit from the therapeutic qualities of CBD.

Join this week as we discover the world of CBD edibles with the co-founder of BOM edibles, Sophie Anderson. We talk about Sophie's time in the US, her inspirations behind BOM and what makes BOM stand out in a busy edible market.

This week I talk to the Pharmacy lead of The Centre for Medicinal Cannabis and the UK Managing Director of Emmac Life Sciences about the Department for Health and Social Care announcement that aims to make cannabis medication more accessible for patients.